Navigation Links
Amgen Highlights Data to Be Presented at ASCO
Date:5/15/2009

factor receptor (IGF-1R)

Lead Author: McCaffery I

Abstract No. 3545 (Saturday, May 30, 2009, 8:00am-12:00pm)

About Vectibix

Vectibix is indicated as a single agent for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal carcinoma after disease progression on, or following fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens. The effectiveness of Vectibix as a single agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free survival. Currently no data demonstrate an improvement in disease-related symptoms or increased survival with Vectibix.

Vectibix Important Product Safety Information

Dermatologic Toxicity: Dermatologic toxicities occurred in 89 percent of patients and were severe (NCI-CTC grade 3 and higher) in 12 percent of patients receiving Vectibix monotherapy. Withhold Vectibix for dermatologic toxicities that are grade 3 or higher or are considered intolerable. If toxicity does not improve to less than or equal to grade 2 within 1 month, permanently discontinue Vectibix. The clinical manifestations included, but were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and skin fissures. Subsequent to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses requiring incisions and drainage were reported.

Infusion Reactions: Severe infusion reactions occurred in approximately 1 percent of patients. Severe infusion reactions included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
2. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
4. Amgen Announces Webcast of 2009 First Quarter Financial Results
5. Amgen to Present at the Barclays Capital Global Healthcare Conference
6. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
7. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
8. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
9. Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
10. Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society
11. Quality of life survey highlights need for holistic approach in elderly residential care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Expectant parents should leave prenatal picture-taking to medical professionals, ... of ultrasound imaging and heartbeat monitors to get "keepsake" ... warns. "Although there is a lack of ... heartbeat monitors, prudent use of these devices by trained ... biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... improve overall health, but a growing body of evidence shows ... review finds. In fact, the benefits were similar to ... researcher Paula Chu, a doctoral candidate at Harvard University,s Health ... trials, found that people randomly assigned to take yoga classes ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... 2014 OutMarket , a provider ... Social Media Cheat Sheets ,” a guide that exposes ... results on the top ten social media networks. ... drive awareness, engagement, and customer service. It can also ... an impact on new networks and weather constantly changing ...
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
... Minn. Mayo Clinic has received investigational ... the Food and Drug Administration ( http://www.fda.gov/ ... mobilize the body,s defense mechanisms to destroy ... first aimed at preventing cancer recurrence. The ...
... News) -- Although not life-threatening, sprains and strains account ... in U.S. emergency departments, according to a new study. ... emergency hotline or scheduled doctor appointments, would spare valuable ... Hospital in Boston, said in the report, recently published ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... this week expressed growing concerns over a rise in rates ... New data released Tuesday at the National HIV Prevention Conference ... that 19 percent of gay and bisexual men, 9 percent ...
... Reporter , TUESDAY, Aug. 16 (HealthDay News) -- Almost half ... and the risk of bladder cancer has increased significantly for ... Smokers now face a four times higher risk of ... years ago, that risk was about three times that of ...
... TUESDAY, Aug. 16 (HealthDay News) -- ,Scientists who identified ... a need for gender-specific drug therapies for some diseases. ... blood serum from more than 3,000 people and found ... in lipids and amino acids. The results prove ...
... , TUESDAY, Aug. 16 (HealthDay News) -- Black women ... are less likely to breast-feed, putting them at greater risk ... a new study. The study, published in the ... found the risk for hormone receptor-negative breast cancer was 50 ...
Cached Medicine News:Health News:Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines 2Health News:Sprained Ankles Straining ER Resources, Study Finds 2Health News:Experts Concerned About Rising HIV Rates Among Poor, Minorities 2Health News:Bladder Cancer Risk Even Higher for Smokers Than Thought 2Health News:Bladder Cancer Risk Even Higher for Smokers Than Thought 3Health News:Blacks at Higher Risk for Resistant Breast Cancer: Study 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
(Date:12/15/2014)... 15, 2014 BerGenBio AS, a ... drug resistant cancers, today announces that it has raised ... from new and existing investors. BerGenBio will ... development of its pipeline of innovative cancer therapeutics, in ... drug candidate, BGB324, a first-in-class selective Axl kinase inhibitor, ...
(Date:12/15/2014)... -- Colorado and Washington State are not ... Oregon , Alaska , ... the November 2014 elections. Photo - ... The benefits of legalizing cannabis are manifold. There ... increased tax revenue for state and local governments, in addition ...
Breaking Medicine Technology:MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2BerGenBio Completes NOK90 Million Fundraising 2CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2
... Aug. 13 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: ... marketing and distribution partner in Japan, has,submitted a ... Japanese Ministry of Health, Labour and Welfare. ... to bring the first drug,treatment option to MPS ...
... Texas, Aug. 13 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... an oral presentation at the American Chemical Society ... August 21, 2007,at 2:50 p.m. Eastern Time. The ... serotonin levels by enzyme inhibitors for the,potential treatment ...
Cached Medicine Technology:BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 2BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 3BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health 4Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 2Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate 3
Inquire...
Inquire...
Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Medicine Products: